IL113112A - Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them - Google Patents

Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them

Info

Publication number
IL113112A
IL113112A IL11311295A IL11311295A IL113112A IL 113112 A IL113112 A IL 113112A IL 11311295 A IL11311295 A IL 11311295A IL 11311295 A IL11311295 A IL 11311295A IL 113112 A IL113112 A IL 113112A
Authority
IL
Israel
Prior art keywords
group
alkyl
cycloalkyl
thiazolidinediones
pharmaceutical compositions
Prior art date
Application number
IL11311295A
Other languages
English (en)
Other versions
IL113112A0 (en
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of IL113112A0 publication Critical patent/IL113112A0/xx
Publication of IL113112A publication Critical patent/IL113112A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11311295A 1994-03-28 1995-03-23 Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them IL113112A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5719294 1994-03-28
JP29517794 1994-11-29

Publications (2)

Publication Number Publication Date
IL113112A0 IL113112A0 (en) 1995-06-29
IL113112A true IL113112A (en) 2000-06-01

Family

ID=26398213

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11311295A IL113112A (en) 1994-03-28 1995-03-23 Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them

Country Status (19)

Country Link
EP (1) EP0751944B1 (hu)
KR (1) KR100340615B1 (hu)
CN (1) CN1045776C (hu)
AT (1) ATE198200T1 (hu)
AU (1) AU683739B2 (hu)
CA (1) CA2186381A1 (hu)
CZ (1) CZ282096A3 (hu)
DE (1) DE69519666T2 (hu)
DK (1) DK0751944T3 (hu)
ES (1) ES2154727T3 (hu)
GR (1) GR3035277T3 (hu)
HU (1) HUT76062A (hu)
IL (1) IL113112A (hu)
MX (1) MX9604430A (hu)
NZ (1) NZ282893A (hu)
PT (1) PT751944E (hu)
RU (1) RU2125053C1 (hu)
TW (1) TW420669B (hu)
WO (1) WO1995026347A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0749430T3 (da) * 1994-03-08 2000-02-07 American Home Prod Thiazolidindion-derivater som antihyperglykæmiske midler
US5889025A (en) * 1996-05-06 1999-03-30 Reddy's Research Foundation Antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
BR9711098B1 (pt) * 1996-07-01 2011-10-04 compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6313113B1 (en) * 1997-04-15 2001-11-06 Reddy-Cheminor, Inc. Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6011031A (en) * 1997-05-30 2000-01-04 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
PT1339678E (pt) 2000-11-27 2007-11-30 Pfizer Prod Inc Agonistas selectivos do receptor ep4 no tratamento de osteoporose
MY148985A (en) * 2006-03-24 2013-06-28 Array Biopharma Inc 2-aminopyridine analogs as glucokinase activators
CN101311167B (zh) * 2007-05-25 2011-04-06 天津药物研究院 1-苯基咪唑烷-2,4-二酮类衍生物及其用途
CN102884062B (zh) 2009-12-23 2016-08-03 嘉世高制药公司 氨基嘧啶激酶抑制剂
AU2012245344B2 (en) 2011-04-22 2017-11-09 Jasco Pharmaceuticals, LLC Aminopyrimidine kinase inhibitors
KR101990605B1 (ko) * 2011-11-04 2019-06-18 자스코 파머수티컬스, 엘엘씨 아미노피리미딘 키나아제 억제제
KR20160004272U (ko) 2015-06-04 2016-12-14 심명보 걸이구가 구비된 케이블행거
KR200488728Y1 (ko) 2017-06-15 2019-03-11 심명보 걸이구가 구비된 케이블행거
EP3658142B1 (en) 2017-07-28 2024-04-17 Applied Therapeutics, Inc. Compositions and methods for treating galactosemia
EP3966320A4 (en) 2019-05-07 2023-10-25 University of Miami TREATMENT AND DETECTION OF HEREDITARY NEUROPATHIES AND ASSOCIATED DISORDERS
KR102433164B1 (ko) * 2020-06-29 2022-08-18 한국전력공사 길이와 각도 조절이 가능한 케이블 행거

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5564586A (en) * 1978-11-09 1980-05-15 Takeda Chem Ind Ltd Thiazolidine derivative
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
JPH065228A (ja) * 1992-06-18 1994-01-14 Mitsubishi Electric Corp 偏向デバイス
TW245716B (hu) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
KR960002625A (ko) * 1994-06-17 1996-01-26 제임스 조셉 드롱 다층 레지스트의 플라즈마 에칭을 위한 방법 및 장치

Also Published As

Publication number Publication date
DK0751944T3 (da) 2001-01-08
IL113112A0 (en) 1995-06-29
KR100340615B1 (ko) 2002-10-18
PT751944E (pt) 2001-03-30
EP0751944B1 (en) 2000-12-20
DE69519666D1 (de) 2001-01-25
WO1995026347A1 (en) 1995-10-05
EP0751944A1 (en) 1997-01-08
CN1144526A (zh) 1997-03-05
TW420669B (en) 2001-02-01
AU2083395A (en) 1995-10-17
KR970701716A (ko) 1997-04-12
HU9602645D0 (en) 1996-11-28
AU683739B2 (en) 1997-11-20
CZ282096A3 (en) 1997-03-12
NZ282893A (en) 1997-07-27
MX9604430A (es) 1997-12-31
ES2154727T3 (es) 2001-04-16
CA2186381A1 (en) 1995-10-05
RU2125053C1 (ru) 1999-01-20
HUT76062A (en) 1997-06-30
DE69519666T2 (de) 2001-04-26
ATE198200T1 (de) 2001-01-15
CN1045776C (zh) 1999-10-20
GR3035277T3 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
IL113112A (en) Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them
HU907896D0 (en) Amine derivatives
MX9709951A (es) Derivados de benzamida y su uso como antagonistas de vasopresina.
HU9700030D0 (en) 2-(1',2',4'-triazol-3'-yloxymethylene)-anilides and their use as pestcontrol agents
ES2001396A6 (es) Procedimiento para la obtencion de derivados de nitrometileno de efecto insecticida.
CA2105503A1 (en) Carboxanilides, their preparation and compositions containing them for controlling harmful fungi
NZ332658A (en) Halo-substituted bis-indolylmaleimide derivatives and pharmaceutical compositions
ES8103070A1 (es) Un procedimiento para preparar un compuesto de guanidinotia-zol
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
CA2082574A1 (en) 3-isoxazolylphenyl compounds, their preparation and their use
GR3035205T3 (en) Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
ES8105290A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbostirilo
DE3889208D1 (de) Thioformamid-Derivate.
HUT59560A (en) Insecticide and acaricide composition containing heterocyclic active component and process for producing intermediates for the active components
ZA824820B (en) A synergistic composition and a process for selectively combating weeds, especially in cereal crops
EP0293839A3 (en) Substituted phenyl (or pyridyl) urea compound and herbicidal composition containing the same as active ingredient
AU1287892A (en) Method of inhibiting the progressive development of diabetes mellitus
JPS55167206A (en) Industrial bactericidal and fungicidal agent
MX9603868A (es) Composicion farmaceutica de derivados de indeno para la regulacion de la apoptosis.
AU653019B2 (en) New urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
ATE44741T1 (de) 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere.

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees